Master in Pharmaceutical biotechnology

Tuition fees are 4,489 USD per year.

Pharmaceutical biotechnology is a master's program at Università degli Studi di Milano, taught in English in Milano, Italy, over two years, intended for students with a bachelor's degree in biotechnology, pharmacy, biology, or a related field. The discipline applies biotechnological methods to the discovery, development, and production of pharmaceutical products, particularly biologics such as therapeutic proteins, antibodies, and vaccines. Students typically study molecular biology, pharmacology, and biochemistry alongside subjects focused on drug development, including how candidate molecules are identified, tested, and manufactured at scale. Coursework often covers recombinant protein production, cell culture technology, and the regulatory requirements that biopharmaceutical products must satisfy before they can be approved for clinical use. Laboratory work gives students practical experience with techniques used in biopharmaceutical research and production, connecting scientific understanding of disease targets to the practicalities of manufacturing safe and effective treatments. Because pharmaceutical biotechnology sits between basic research and industrial production, programs in this area typically also address quality control, good manufacturing practice, and the steps involved in bringing a biotechnological drug from laboratory discovery through clinical trials to market. Graduates pursue careers in pharmaceutical and biotechnology companies, contract research and manufacturing organizations, regulatory agencies, and research institutions focused on drug development. Others continue into doctoral study exploring specific therapeutic areas or production technologies. The field suits students interested in applying molecular biology directly to the development of medicines. Milano's concentration of pharmaceutical and biotechnology companies provides relevant context for this English-medium program, which trains international students for roles across the biopharmaceutical industry.